LTR PHARMA LTD

0.415

-0.010-2.35%

成交量：13.49萬

成交額：5.68萬

市值：7,538.27萬

市盈率：-5.32

高：0.440

開：0.440

低：0.415

收：0.425

52周最高：0.810

52周最低：0.350

股本：1.82億

流通股本：1.01億

量比：0.84

換手率：0.13%

股息：- -

股息率：- -

每股收益(TTM):-0.078

每股收益(LYR):-0.078

淨資產收益率：-54.73%

總資產收益率：-32.96%

市淨率：3.72

市盈率(LYR):-5.32

資料載入中...

總覽公司新聞資訊公告

概念

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

LTR Pharma旗下口服液Oroflow成為其鼻內給藥平台首個進入臨床評估的胃腸道應用

美股速递

·

06/24

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/LTP.AU"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"LTP.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"LTP.AU\",,,,,undefined,":{"symbol":"LTP.AU","market":"AU","secType":"STK","nameCN":"LTR PHARMA LTD","latestPrice":0.415,"timestamp":1789625520000,"preClose":0.425,"halted":0,"volume":134866,"delay":0,"changeRate":-0.023529411764705903,"nameEN":"LTR PHARMA LTD","floatShares":100829062,"shares":181645077,"eps":-0.078,"marketStatus":"已收盤","change":-0.01,"latestTime":"09-17 16:12:00 AEST","open":0.44,"high":0.44,"low":0.415,"amount":56767,"amplitude":0.058824,"askPrice":0.425,"askSize":12203,"bidPrice":0.415,"bidSize":31234,"shortable":3,"etf":0,"ttmEps":-0.078,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1789689600000},"marketStatusCode":5,"adr":0,"listingDate":1702126800000,"exchange":"ASX","adjPreClose":0.425,"openAndCloseTimeList":[[1789603200000,1789624800000]],"volumeRatio":0.841607,"lotSize":0,"tradeCurrency":"AUD","auctionPricing":{"symbol":"LTP.AU","preClose":0.425,"auctionPrice":0.44,"auctionVolume":10000,"auctionTime":1789624850186,"referencePrice":0.415,"referenceTime":1789635600828,"auction":3,"marketStatus":"盘后竞价","timestamp":1789624850186}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"LTP.AU\",,,,,undefined,":{"symbol":"LTP.AU","floatShares":100829062,"roa":"-32.96%","roe":"-54.73%","lyrEps":-0.078,"volumeRatio":0.841607,"shares":181645077,"dividePrice":0,"high":0.44,"amplitude":0.058824,"preClose":0.425,"low":0.415,"week52Low":0.35,"pbRate":"3.72","psRate":"104.13","week52High":0.81,"institutionHeld":0,"latestPrice":0.415,"committee":0.438129,"eps":-0.078,"divideRate":0,"volume":134866,"delay":0,"ttmEps":-0.078,"open":0.44,"prevYearClose":0.72,"prevWeekClose":0.455,"prevMonthClose":0.505,"prevQuarterClose":0.545,"fiveDayClose":0.465,"twentyDayClose":0.495,"sixtyDayClose":0.585},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LTP.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LTP.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LTP.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1169800652","title":"LTR Pharma旗下口服液Oroflow成為其鼻內給藥平台首個進入臨床評估的胃腸道應用","url":"https://stock-news.laohu8.com/highlight/detail?id=1169800652","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169800652?lang=zh_tw&edition=fundamental","pubTime":"2026-06-24 06:23","pubTimestamp":1782253391,"startTime":"0","endTime":"0","summary":"LTR Pharma宣布，其产品Oroflow口服液已进入临床评估阶段，标志着该公司鼻内给药平台技术首次成功拓展至胃肠道应用领域。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LTP.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/LTP.AU\",params:#limit:6,delay:true,,,undefined,":[]}}